The genotyping services offered by the Genomics Core include the Illumina BeadArray technology for SNPs, and the ABI technology for resolution of fluorescently tagged PCR products encompassing STRPs or other genomic region(s) of interest. Both technologies are widely used by a large number of NHGRI investigators;16 investigators from five different branches used the Core services this year. The Core received 290 service requests in FY2012, nearly twice as many as last year (150 requests). This increase covers a 15-month period (June 11 - Aug 12), and when annualized, requests increased 55% from FY2011. The Core processed 13,140 DNA samples this year, over 2-fold increase from last year (6,400 samples), and a 65% increase for a comparable 12-month time period. For the past three years, there has been a steady increase in the number of service requests (108, 150, 290) and in number of samples (730, 6,400, 13,140) processed by the Core. SNP assays (and the arrays) used included GoldenGate (mouse1440) and Infinium (HumanOmni2.5, HumanOmniExpress, 370CNV, and Human 450K Methylation). The number of samples processed and the genotypes generated were for mouse genotype (758, 1M), human genotype (2,400, 1119M) and methylation (96, 36M) studies. As anticipated from the use of high-density SNP arrays, nearly all the genotypes generated this year (1156M) were from SNP technology, though the number of samples processed with SNP technology (3,254) accounted for a third of those processed with ABI technology (9,886). ABI technology is capable of separating fluorescently labeled PCR products at single-base resolution, and continues to accommodate novel applications. We established this capability to help develop an efficient screening strategy for mutagenesis efforts in zebrafish. This strategy helped find germline transmitting founder fish and determines the size of the insertion or deletion mutation generated by the ZFNs (zinc‐finger nucleases) and TALENs (transcription activator like effector nucleases) technologies. Zebrafish DNA samples (8,810) accounted for 90% of all the DNA processed with ABI technology this year (9,886), and doubled from last year (4,343). The Core continues to provide ABI-based STRP genotyping, and over 1000 DNA samples were genotyped for studies such as deletion mapping by MLPA, microsatellite instability, mouse speed congenics, sample characterization, and parent-of-origin studies. The Core uses genotyping to help investigators identify samples by fingerprinting DNA samples with a set of highly polymorphic STRP markers. We have now added a relatively high-density SNP chip at an affordable cost (192,000 SNPs;$39 per sample). The Core processed 1,680 DNA samples using these chips for NISC. These genotypes generated by the Core, in general, covered a variety of applications, such as linkage, association, scanning focus regions for fine mapping of linked loci, copy number variation, identification of deletion intervals, parent of origin of deletions, speed congenics, methylation/expression in cancer, variations introduced by the iPS technology, mosaicism, uniparental disomy, homozygosity mapping and nonclassical linkage analysis, among others. While genotyping was the main activity of the Core, limited physical mapping and sequencing services, as well as access to DNA panels were also offered. The Core also assists investigators with data analysis. In FY2010, the Core purchased and installed an Illumina iScan that allowed genotyping with higher density (2.5M) and higher throughput (OmniExpress) SNP chips. This has substantially extended our ability to process increased number of samples (this year, 3284 samples) and generate large number of genotypes (1156M).

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Scientific Cores Intramural Research (ZIC)
Project #
1ZICHG200346-05
Application #
8565587
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2012
Total Cost
$645,551
Indirect Cost
Name
National Human Genome Research Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Malicdan, May Christine V; Vilboux, Thierry; Ben-Zeev, Bruria et al. (2018) A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency. Hum Mutat 39:69-79
Chen, Y-C; Sudre, G; Sharp, W et al. (2018) Neuroanatomic, epigenetic and genetic differences in monozygotic twins discordant for attention deficit hyperactivity disorder. Mol Psychiatry 23:683-690
Kimble, Danielle C; Lach, Francis P; Gregg, Siobhan Q et al. (2018) A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families. Hum Mutat 39:237-254
Mendonca, Leonardo O; Malle, Louise; Donovan, Frank X et al. (2017) Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN. J Clin Immunol 37:445-451
Demirkaya, Erkan; Zhou, Qing; Smith, Carolyne K et al. (2017) Brief Report: Deficiency of Complement 1r Subcomponent in Early-Onset Systemic Lupus Erythematosus: The Role of Disease-Modifying Alleles in a Monogenic Disease. Arthritis Rheumatol 69:1832-1839
Kwon, Erika M; Connelly, John P; Hansen, Nancy F et al. (2017) iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations. Proc Natl Acad Sci U S A 114:1964-1969
Mirabello, Lisa; Khincha, Payal P; Ellis, Steven R et al. (2017) Novel and known ribosomal causes of Diamond-Blackfan anaemia identified through comprehensive genomic characterisation. J Med Genet 54:417-425
Dewan, Ramita; Pemov, Alexander; Dutra, Amalia S et al. (2017) First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. BMC Cancer 17:127
Murdock, David R; Donovan, Frank X; Chandrasekharappa, Settara C et al. (2017) Whole-Exome Sequencing for Diagnosis of Turner Syndrome: Toward Next-Generation Sequencing and Newborn Screening. J Clin Endocrinol Metab 102:1529-1537
Watkins-Chow, Dawn E; Varshney, Gaurav K; Garrett, Lisa J et al. (2017) Highly Efficient Cpf1-Mediated Gene Targeting in Mice Following High Concentration Pronuclear Injection. G3 (Bethesda) 7:719-722

Showing the most recent 10 out of 40 publications